BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8250240)

  • 1. Testing potential gyrase inhibitors of bacterial DNA gyrase: a comparison of the supercoiling inhibition assay and "cleavable complex" assay.
    Barrett JF; Bernstein JI; Krause HM; Hilliard JJ; Ohemeng KA
    Anal Biochem; 1993 Oct; 214(1):313-7. PubMed ID: 8250240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
    Wu LC; Shahied SI
    Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High pressure modulation of Escherichia coli DNA gyrase activity.
    Chilukuri LN; Fortes PA; Bartlett DH
    Biochem Biophys Res Commun; 1997 Oct; 239(2):552-6. PubMed ID: 9344868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
    Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
    J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of norfloxacin inhibition of DNA gyrase induced by a 28 KDal DNA binding protein.
    Landini P; Pagani L; Debiaggi M; Cereda PM; Romero E
    Microbiologica; 1989 Jul; 12(3):247-55. PubMed ID: 2550742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting nucleotide thiophosphates to probe mechanistic aspects of Escherichia coli DNA gyrase.
    Cullis PM; Maxwell A; Weiner DP
    Biochemistry; 1997 May; 36(20):6059-68. PubMed ID: 9166776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyrase.
    Hilliard JJ; Krause HM; Bernstein JI; Fernandez JA; Nguyen V; Ohemeng KA; Barrett JF
    Adv Exp Med Biol; 1995; 390():59-69. PubMed ID: 8718602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two short peptides including segments of subunit A of Escherichia coli DNA gyrase as potential probes to evaluate the antibacterial activity of quinolones.
    Marchetto R; Nicolás E; Castillo N; Bacardit J; Navia M; Vila J; Giralt E
    J Pept Sci; 2001 Jan; 7(1):27-40. PubMed ID: 11245203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
    Jain P; Nagaraja V
    Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
    J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complex of DNA gyrase and quinolone drugs on DNA forms a barrier to the T7 DNA polymerase replication complex.
    Wentzell LM; Maxwell A
    J Mol Biol; 2000 Dec; 304(5):779-91. PubMed ID: 11124026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA gyrase as a drug target.
    Maxwell A
    Trends Microbiol; 1997 Mar; 5(3):102-9. PubMed ID: 9080608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
    Wu P; Lawrence LE; Denbleyker KL; Barrett JF
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy coupling in Escherichia coli DNA gyrase: the relationship between nucleotide binding, strand passage, and DNA supercoiling.
    Bates AD; O'Dea MH; Gellert M
    Biochemistry; 1996 Feb; 35(5):1408-16. PubMed ID: 8634270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells.
    Snyder RD
    Environ Mol Mutagen; 2000; 35(1):13-21. PubMed ID: 10692223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of DNA supercoiling and rpoS sigma factor in the osmotic and growth phase-dependent induction of the gene osmE of Escherichia coli K12.
    Conter A; Menchon C; Gutierrez C
    J Mol Biol; 1997 Oct; 273(1):75-83. PubMed ID: 9367747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomally encoded gyrase inhibitor GyrI protects Escherichia coli against DNA-damaging agents.
    Chatterji M; Sengupta S; Nagaraja V
    Arch Microbiol; 2003 Nov; 180(5):339-46. PubMed ID: 13680098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of DNA gyrase by ES-1273, a novel DNA gyrase inhibitor.
    Oyamada Y; Yamagishi J; Kihara T; Yoshida H; Wachi M; Ito H
    Microbiol Immunol; 2007; 51(10):977-84. PubMed ID: 17951987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of DNA gyrase inhibition by microcin B17 analogs with altered bisheterocyclic sites.
    Zamble DB; Miller DA; Heddle JG; Maxwell A; Walsh CT; Hollfelder F
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7712-7. PubMed ID: 11427730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.